11
What to Treat Single sick animals? In-contact animals? Whole groups? For CBPP Nicholas et al. (2007) demonstrated that treating whole herds with Advocin was effective in eliminating CBPP from a region of Namibia.

What to Treat - Eläinten terveys ETT ry | ett.fi · What to Treat • Single sick animals? ... Tylosin >8 µg/ml and Tilmicosin 32 µg/ml had mutations in 23S ... • A diagnosis

Embed Size (px)

Citation preview

What to Treat

• Single sick animals?

• In-contact animals?

• Whole groups?

For CBPP Nicholas et al. (2007) demonstrated that treating whole herds with Advocin was effective in eliminating CBPP from a region of Namibia.

Antimicrobials may not be

effective

• Site (s) of the infection

• Mycoplasmastatic effect

• Animal infection too severe – treated too late

• Organism protected by biofilm

• Individual animal treated, but infection spread to others, allowing re-

infection.

•ANTIMICROBIAL RESISTANCE

• But AR is not the only explanation

Antimicrobial effectiveness

Breakpoints

A measure that relates in vitro MIC results to in vivo effect.

i.e. the maximum threshold for predicting successful antimicrobial

treatment.

For Veterinary Mycoplasma Infections breakpoints have not been

determined.

• Therefore the interpretation of Veterinary Mycoplasma MIC results can

not officially be defined into susceptible, intermediate or resistant.

UK Mycoplasma bovis MIC Results

Mycoplasma bovis Antimicrobial sensitivity - Advocin

0

2

4

6

8

10

12

14

16

18

20

<0.06 0.06 0.12 0.25 0.5 1 2 4 8 16 32 64 >64

Antimicrobial conc in ug/ml

Nu

mb

er

of

iso

late

s

0

10

20

30

40

50

60

70

80

90

100

Perc

en

tag

e

MIC

50%

90%

Cumulative MIC

UK Mycoplasma bovis MIC Results

Mycoplasma bovis Antimicrobial sensitivity - Tilmicosin

0

2

4

6

8

10

12

14

16

18

20

<0.06 0.06 0.12 0.25 0.5 1 2 4 8 16 32 64 >64

Antimicrobial conc in ug/ml

Nu

mb

er

of

iso

late

s

0

10

20

30

40

50

60

70

80

90

100

Perc

en

tag

e

MIC

50%

90%

Cumulative MIC

UK Mycoplasma bovis MIC Results

Mycoplasma bovis Antimicrobial sensitivity - Erythromycin

0

2

4

6

8

10

12

14

16

18

20

<0.12 0.12 0.25 0.5 1 2 8 32 >32

Antimicrobial conc in ug/ml

Nu

mb

er

of

iso

late

s

0

10

20

30

40

50

60

70

80

90

100

Perc

en

tag

e

MIC

50%

90%

Cumulative MIC

UK Mycoplasma bovis MIC Results

45 samples (2004-2009) Test for Trend (Cuzick, 1985)

Range MIC50 MIC90

The results for each antimicrobial

are 2-sided p values.

tylosin 0.25->32 32 >32 p=0.407*

tilmicosin 1->32 >32 >32 p<0.001 decreasing trend

lincomycin 0.25->32 8 >32 p=0.010 decreasing trend

clindamycin <0.12->32 8 >32 p=0.001 decreasing trend

erythromycin 32->32 >32 >32 p=0.263

chloramphenicol 0.25-32 8 32 p=0.016 increasing trend

florfenicol 0.5-32 8 32 p=0.229

spectinomycin 2->32 8 >32 p=0.288

oxytetracycline 0.12->32 8 32 p=0.001 increasing trend

danofloxacin 0.12-32 0.25 8 p=0.002 increasing trend

enrofloxacin 0.12->32 0.5 32 p=0.022 increasing trend

marbofloxacin 0.25->32 1 >32 p=0.403*

tulathromycin 0.25->128 2 >128 p=0.381*

Antimicrobial Resistance

• Antimicrobial resistance can be induced in vitro in a few steps by

subculturing at sub-MIC levels.

• Resistance is often the result of single point mutations in a gene.

Fluoroquinolone: Mutation in gyrA, similar to that described for E. coli

- - - - - -

2

5

0 - - - - - - - - -

2

6

0 - - - -

M.

bovis S G A T T C T T C G G T T T A T G A A G C A

NCTC R G A T T C T T C G G T T T A T A A A G C A

400B07 R G A T T C T T C G G T T T A T A A A G C A

420B07 R G A T T T T T C G G T T T A T G A A G C A

Tylosin >8 µg/ml and Tilmicosin 32 µg/ml had mutations in 23S rRNA

consistent with antimicrobial resistance.

Lerner et al. Vet Micro. In press

Treatment

• Chemotherapy/antimicrobial treatment should be last resort.

• A diagnosis and understanding of pharmacokinetics and

pharmacodynamics is beneficial,

however a lot of this knowledge has been obtained by the

pharmaceutical companies - read the bottle / instructions.

• An awareness of the current antimicrobial resistance status will help in

selecting an effective treatment.

Mycoplasma bovis: Silent and Deadly – The Enemy

• Many Mycoplasma species can be detected in cattle, some causing serious

disease.

• Prevention is easier than cure

Summary

Mycoplasma bovis can enter the herd unnoticed, silent and

ready to attack……

• The organisms are fastidious, but cunning with an armoury of defences

• Diagnostic testing before introducing new stock can prevent infection

• Accurate diagnosis and strategic early treatment with effective antimicrobials

may reduce the impact of this disease invasion

Mycoplasma bovis: Silent and Deadly – The Enemy

THANK YOU

FOR LISTENING AND FOR INVITING ME